Correction to: Improved quality of life in cystic fibrosis patients observed up to 36 months after starting Elexacaftor/Tezacaftor/Ivacaftor treatment

Journal of Patient-Reported Outcomes 2026 Open access

Read full text

Authors: Francesca Buniotto, G. Tridello, A. Scolari, Ilaria Meneghelli, Emily Pintani, Sandra Perobelli, Marco Cipolli

DOI: 10.1186/s41687-025-00976-0

Cited by: 0

Fields of Study & Subjects

Cystic Fibrosis Research Advances Pharmacogenetics and Drug Metabolism Inhalation and Respiratory Drug Delivery